Apellis Pharmaceuticals Inc (APLS) — Working Capital to Net Assets Ratio
Apellis Pharmaceuticals Inc (APLS) has a Working Capital to Net Assets ratio of 179.4% as of March 2026. Working capital of $744.57 Million (current assets of $1.03 Billion minus current liabilities of $283.45 Million) is measured against net assets of $414.92 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Apellis Pharmaceuticals Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Apellis Pharmaceuticals Inc Working Capital to Net Assets (2013–2025)
This chart shows how Apellis Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 179.4%, reflecting working capital of $744.57 Million against net assets of $414.92 Million USD. For the complete balance sheet picture, see Apellis Pharmaceuticals Inc (APLS) total assets.
Annual Working Capital to Net Assets for Apellis Pharmaceuticals Inc (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Apellis Pharmaceuticals Inc from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check APLS cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 186.7% | $691.24 Million | $370.15 Million | $1.01 Billion | $323.60 Million | ▼ -77.3 pp |
| 2024 | 264.0% | $603.45 Million | $228.54 Million | $788.95 Million | $185.51 Million | ▼ -2.6 pp |
| 2023 | 266.7% | $518.74 Million | $194.52 Million | $766.33 Million | $247.59 Million | ▼ -58.2 pp |
| 2022 | 324.9% | $551.91 Million | $169.87 Million | $719.52 Million | $167.61 Million | ▼ -23.5 pp |
| 2021 | 348.4% | $692.20 Million | $198.66 Million | $824.05 Million | $131.85 Million | ▼ -37.2 pp |
| 2020 | 385.6% | $788.87 Million | $204.56 Million | $917.19 Million | $128.33 Million | ▼ -512.2 pp |
| 2019 | 897.9% | $307.34 Million | $34.23 Million | $373.09 Million | $65.75 Million | ▲ +782.7 pp |
| 2018 | 115.2% | $185.41 Million | $160.97 Million | $202.44 Million | $17.02 Million | ▼ -2.6 pp |
| 2017 | 117.8% | $175.46 Million | $148.94 Million | $182.02 Million | $6.55 Million | ▲ +18.1 pp |
| 2016 | 99.7% | $23.73 Million | $23.79 Million | $27.37 Million | $3.64 Million | ▲ +0.1 pp |
| 2015 | 99.6% | $34.84 Million | $34.98 Million | $38.04 Million | $3.20 Million | ▲ +0.1 pp |
| 2014 | 99.6% | $13.17 Million | $13.22 Million | $14.25 Million | $1.08 Million | ▼ -0.2 pp |
| 2013 | 99.8% | $4.51 Million | $4.52 Million | $5.19 Million | $676.96K | — |